Zoetis EVP Acquires $9.4k in Phantom Stock Units (ZTS)
Zoetis Inc.
Subscribe to track ZTS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Zoetis EVP Acquires $9.4k in Phantom Stock Units (ZTS)
Company: Zoetis Inc. (ZTS) Form: 4 | Filed: 2025-10-14 Significance: Low
Insider: FULLER JULIE Title: Executive Vice President | Relationship: Officer
Transaction: • Type: Award • Shares: 201.7367 • Price: $46.71 • Value: $9,423.30 • Owned After: 387.6519
Key Insight: This is a routine acquisition of phantom stock units through a company savings plan, not an open-market purchase, indicating low trading significance.
Market Context: The transaction is part of a supplemental savings plan, a common form of executive compensation, and does not necessarily reflect new insider sentiment.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Zoetis Inc. (ZTS)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An Executive Vice President at Zoetis acquired phantom stock units valued at approximately $9,400 as part of a supplemental savings plan. This is a routine, non-discretionary transaction and does not represent a new investment decision by the insider.
- Market Impact: Neutral. The transaction is too small and its nature (part of a savings plan) is unlikely to influence market perception or stock price.
Company Information
| Field | Value |
|---|---|
| Company | Zoetis Inc. |
| Ticker Symbol | ZTS |
| CIK | 0001555280 |
| Industry | PHARMACEUTICAL PREPARATIONS [2834] |
Insider Information
| Field | Value |
|---|---|
| Name | FULLER JULIE |
| CIK | 0001839804 |
| Title/Position | Executive Vice President |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-10 |
| Transaction Code | A (Grant, award, or other acquisition) |
| Security Type | Phantom Stock Unit |
| Shares Involved | 201.7367 |
| Price Per Share | $46.71 |
| Total Value | $9,423.30 |
| Shares Owned After | 387.6519 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is an award of phantom stock units under a savings plan, not an open-market purchase. Such transactions are typically pre-scheduled or automatic and do not signal a change in the insider's outlook on the company. The value is negligible relative to the company's market capitalization.
Volume & Sentiment
- Expected Volume Impact: None. As this is not an open-market trade, it has no direct impact on trading volume.
- Sentiment Indicator: Neutral. This type of filing is common and is viewed by the market as part of a standard compensation structure rather than a bullish or bearish signal.
Investment Insights
Positive Market Indicators
- The acquisition, although routine, incrementally increases the insider's alignment with shareholder interests.
Risk Factors
- No direct risk factors are indicated by this filing. It is a standard course of business transaction.
Key Takeaways
- Routine Compensation: The acquisition is part of the Zoetis Supplemental Savings Plan, as noted in the filing's footnotes.
- Not an Open-Market Buy: This is not a discretionary purchase of shares with the insider's own capital, which would have carried more weight.
- Low Significance: The small dollar amount and the nature of the transaction render it of low significance for investment analysis.
Contextual Analysis
Timing Significance
- The timing of the transaction is tied to the mechanics of the savings plan and does not appear to be correlated with any specific market event or inside information.
Transaction Context
- Footnote 1 clarifies the nature of the transaction: "These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service..." This confirms the transaction is part of a deferred compensation or savings program.
- Footnote 2 explains that each unit represents a fraction of a phantom share plus cash-equivalents, with its value tied to Zoetis common stock.
Company Context
- Zoetis is a major player in the animal health industry. This filing represents a minor, operational event within its executive compensation framework and does not provide insight into the company's current performance or strategic direction.
Risk Assessment
Risk Level: Low
Risk Factors
- This filing does not introduce any new risk factors. The primary risk is misinterpreting this routine award as a bullish insider signal.
Market Considerations
- Investors should differentiate between discretionary open-market trades and automatic, plan-related acquisitions.
- This filing is informational and should not be a factor in an investment thesis for ZTS.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-14 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
